PHARMACOLOGICAL CONSIDERATIONS IN THE TREATMENT OF MYASTHENIA GRAVIS

被引：5

作者：

GLASER, GH

机构：

来源：

关键词：

D O I：

10.1016/S1054-3589(08)60086-1

中图分类号：

学科分类号：

摘要：

引用

页码：113 / 160

页数：48

共 219 条

[1]

ADAMS RD, 1962, DISEASES MUSCLE

[2]

AESCHLIMAN JA, 1931, J PHARMACOL EXP THER, V43, P113

[3]

ANDERSON HJ, 1953, LANCET, V265, P1291

[4]

ARANOW H, 1958, J CHRON DIS, V6, P113

BARRNETT, RJ .

Bennett, AE ;

Cash, PT .

ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1943, 49 (04) :537-547

[7]

Bernard C, 1857, LECONS EFFETS SUBSTA

BICKERSTAFF, ER ;

EVANS, JV ;

WOOLF, AL .

[9] THE INTRAMUSCULAR NERVE ENDINGS IN MYASTHENIA GRAVIS [J].

BICKERSTAFF, ER ;

WOOLF, AL .

[10] THE FINE STRUCTURE OF THE NEUROMUSCULAR JUNCTION OF THE FROG [J].

BIRKS, R ;

HUXLEY, HE ;

KATZ, B .

JOURNAL OF PHYSIOLOGY-LONDON, 1960, 150 (01) :134-+